Avinger (AVGR)
(Delayed Data from NSDQ)
$1.67 USD
-0.09 (-5.11%)
Updated Jul 22, 2024 03:49 PM ET
After-Market: $1.70 +0.03 (1.80%) 4:46 PM ET
3-Hold of 5 3
A Value C Growth F Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AVGR 1.67 -0.09(-5.11%)
Will AVGR be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for AVGR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AVGR
Are Medical Stocks Lagging Avinger (AVGR) This Year?
Asensus Surgical (ASXC) Reports Q1 Loss, Tops Revenue Estimates
AVGR: What are Zacks experts saying now?
Zacks Private Portfolio Services
IQVIA Holdings (IQV) Tops Q1 Earnings and Revenue Estimates
TransMedics (TMDX) Beats Q1 Earnings and Revenue Estimates
Avinger (AVGR) Upgraded to Buy: What Does It Mean for the Stock?
Other News for AVGR
Avinger Announces Closing of up to $24 Million Public Offering
Avinger announces pricing of up to $24M public offering
Avinger prices 3.61M shares at $1.66 in public offering
Why Streamline Health Solutions Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
12 Health Care Stocks Moving In Wednesday's Intraday Session